Morgan Stanley
CCEL icon

Morgan Stanley’s Cryo-Cell International CCEL Stock Holding History

Morgan Stanley’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93K Buy
605
+4
+0.7% +$14 ﹤0.01% 7412
2026
Q1 		$2.13K Hold
601
– – ﹤0.01% 7325
2025
Q4 		$2.07K Buy
601
+1
+0.2% +$4 ﹤0.01% 7236
2025
Q3 		$2.78K Sell
600
-1
-0.2% -$5 ﹤0.01% 7234
2025
Q2 		$3.12K Hold
601
– – ﹤0.01% 7142
2025
Q1 		$3.83K Hold
601
– – ﹤0.01% 7050
2024
Q4 		$4.46K Buy
601
+1
+0.2% +$8 ﹤0.01% 7033
2024
Q3 		$3.82K Sell
600
-1
-0.2% -$7 ﹤0.01% 6984
2024
Q2 		$4.57K Buy
601
+1
+0.2% +$8 ﹤0.01% 6870
2024
Q1 		$4.48K Hold
600
– – ﹤0.01% 6918
2023
Q4 		$3.45K Buy
600
+200
+50% +$1.03K ﹤0.01% 6928
2023
Q3 		$2.1K Hold
400
– – ﹤0.01% 7122
2023
Q2 		$2.43K Hold
400
– – ﹤0.01% 7153
2023
Q1 		$1.21K Sell
400
-400
-50% -$1.54K ﹤0.01% 7324
2022
Q4 		$3.38K Hold
800
– – ﹤0.01% 7248
2022
Q3 		$5K Hold
800
– – ﹤0.01% 7242
2022
Q2 		$5K Buy
800
+400
+100% +$2.56K ﹤0.01% 7392
2022
Q1 		$3K Hold
400
– – ﹤0.01% 7674
2021
Q4 		$5K Sell
400
-300
-43% -$3.74K ﹤0.01% 7633
2021
Q3 		$8K Buy
+700
New +$8.62K ﹤0.01% 7386

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's CCEL Position: Q2 2026 in Review

Morgan Stanley increased its Cryo-Cell International (CCEL) stake by 0.67% in Q2 2026, buying an estimated $14 and bringing the position to 605 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #7412.

Morgan Stanley first reported a position in CCEL in Q3 2021 and has held it in 20 quarters since. The position peaked at $8K in Q3 2021. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.

  • Morgan Stanley held 605 shares of Cryo-Cell International worth $1.93K as of Q2 2026.
  • Morgan Stanley bought 4 Cryo-Cell International shares in Q2 2026, an estimated $14.
  • Cryo-Cell International made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7412 holding.
  • Morgan Stanley first reported a position in Cryo-Cell International in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Cryo-Cell International position peaked at $8K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.